AEDNX | EVDAX | AEDNX / EVDAX | |
Total Expense Ratio | 1.48 | 2.02 | 73% |
Annual Report Gross Expense Ratio | 1.50 | 2.11 | 71% |
Fund Existence | 15 years | 22 years | - |
Gain YTD | 5.467 | 6.546 | 84% |
Front Load | N/A | 3% | - |
Min. Initial Investment | 100000 | 2000 | 5,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 59.7M | 96.4M | 62% |
Annual Yield % from dividends | 0.19 | 0.87 | 22% |
Returns for 1 year | 5.86 | 6.87 | 85% |
Returns for 3 years | 16.11 | 0.99 | 1,634% |
Returns for 5 years | 24.87 | 58.88 | 42% |
Returns for 10 years | 41.67 | 74.52 | 56% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VRSCX | 22.40 | 0.22 | +0.99% |
Voya SmallCap Opportunities Port R6 | |||
SHPAX | 19.36 | 0.10 | +0.52% |
Saratoga Health & Biotechnology A | |||
WSTCX | 26.94 | 0.11 | +0.41% |
Macquarie Science and Technology C | |||
IBNCX | 24.58 | 0.08 | +0.33% |
Macquarie Balanced Fund Class C | |||
ARRQX | 22.98 | 0.05 | +0.22% |
Aristotle Value Equity R6 |